next level semaglutide treatment flexibility. Benefits of both GLP-1 and GIP medications in a single injection once weekly. Great for those who have plateaued on mono-therapy! Book a consult now and make weight Semaglutide: The Drug of Today

NICE recommends discontinuing treatment if a patient has not lost at least 5% of initial body weight after 12 weeks on orlistat or liraglutide at maintenance dose

However, the sustained-release properties of Thorne Researchs Glutathione-SR protect it from stomach acid and digestive enzymes, allowing slower release and a more steady level in the blood of this essential nutrient.*

These side effects are generally mild and tend to decrease over time

Tirzepatide, for example, shows stronger appetite suppression for some patients and may produce sustained results with lower dosespotentially reducing long-term cost and side effect burden

Rotating injection sites reduces this risk